Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect
Recruiting
Phase 4
Interventional Study
Atrial Septal Defect (ASD)
Dexmedetomidine
Delirium - Postoperative
Stress Response
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 3 – 12
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Alexandria University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this randomized trial is to determine efficacy of dexmedetomidine in improving quality of recovery in pediatric patients undergoing interventional catheter closure of ASD while maintaining the hemodynamic parameters. Additionally he stress reducing effects of dexmedetomidine will be investigated in this population .
The main questions it aims to answer are:
Does Dexmedetomidine mainta…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pediatric Patients 3-12 years of age admitted for device closure of ASD secundum
Exclusion Criteria:
* ASA IV, V
* Neurological problems (cerebral palsy, mental retardation, etc.,)
* Children with chromosomal abnormalities or other multiple congenital anomalies or other comp…
Contacts